Antiplatelet Therapy in Patients With COVID-19-More Is Less?

JAMA. 2022 Jan 18;327(3):223-224. doi: 10.1001/jama.2021.23866.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants
  • COVID-19*
  • Hospital Mortality
  • Humans
  • Platelet Aggregation Inhibitors* / therapeutic use
  • SARS-CoV-2

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors